Swedish drug firm AB Astra ASTS.ST> share rise 48 crown 690 hour trading Stockholm Bourse amid hope research anti-viral drug promising result treatment Acquired Immune Deficiency Syndrome (AIDS). Stockbrokers share climbed amid heavy institutional buying rise reaction optimistic assessment future product firm's annual report release week. Brokers Enskilda Fondkommission report month Astra leader anti-viral drugs. Although Enskilda Astra breakthrough develop specific drug treat Acquired Immune Deficiency Syndrome note investor discover firm's approach promising. "It clear Astra tradition anti-viral research prove valuable fight disease" report Enskilda investment banking unit Skandinaviska Enskilda Banken SEBS.ST> said. Company official reach comment cause today's share rise. REUTER 